Daxor Corporation (DXR)

Überblick Nachrichten Preisverlauf Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1117)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DXR Daxor Corporation	9.10	56.52M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	451.71	160.56B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	154.99	43.95B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	74.52	36.34B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	43.77	35.94B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	223.75	32.65B	5.40B	1.49B	1.78B	10.12

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-05-16	Eingeleitet	Ascendiant Capital Markets	Buy

Daxor Corporation Aktie (DXR) Neueste Nachrichten

Finanzdaten der Daxor Corporation-Aktie (DXR)

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation Aktie (DXR) Neueste Nachrichten

[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan

Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - gurufocus.com

Michel, Daxor CFO, buys $9,900 in DXR stock - investing.com

Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India

DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan

DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI

Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn

Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget

Daxor’s Blood Volume Analysis Metric Validated as Uniquely - globenewswire.com

Common leak scores stayed low while Daxor measured 20% hourly leak - Stock Titan

Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia

Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan

Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn

Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire

Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks

Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus

Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions - marketscreener.com

[N-CEN] DAXOR CORP SEC Filing - Stock Titan

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha - MarketBeat

DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView

Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus

Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com

Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks

ICU blood volume test linked to 66% fewer deaths goes portable - Stock Titan

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire

Virtual investor conference to feature Daxor CEO’s 30-minute briefing - Stock Titan

Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir

Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus

Daxor issues update in Letter to Shareholders - TipRanks

Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus

Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView

7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com

Daxor Corporation Reports 2025 Fiscal Year Results: - GlobeNewswire

DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan

Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Finanzdaten der Daxor Corporation-Aktie (DXR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie DXR